News

Filter

Current filters:

Global

201 to 210 of 95973 results

Oncothyreon acquires Alpine Biosciences

Oncothyreon acquires Alpine Biosciences

12-08-2014

US biotech firm Oncothyreon says that it has acquired Alpine Biosciences, of Seattle, Washington, a privately…

Alpine BiosciencesBiotechnologyBusiness FinanceImmunotherapyMedicineMergers & AcquisitionsOncologyOncothyreonRare diseasesUSA

OPKO’s Rayaldee Ph III trial meets primary endpoints in SHPT

12-08-2014

US drugmaker OPKO Health has released positive top-line results from the first pivotal Phase III trial…

Endocrine systemJoel MelnickNephrology and HepatologyOPKO HealthPharmaceuticalRayaldeeResearchUSAVitamin D

Amgen and Novartis applauded for support of investor principles in biosimilar industry

Amgen and Novartis applauded for support of investor principles in biosimilar industry

12-08-2014

A coalition of institutional investors who have over $430 billion in assets has commended Amgen and Novartis…

AmgenBiosimilarBiosimilarsFinancialNovartisSandozUSA

Synta appoints Sanofi's Anne Whitaker as chief executive

Synta appoints Sanofi's Anne Whitaker as chief executive

12-08-2014

Coming from her position as president of Sanofi’s North American pharma division, Anne Whitaker has…

Anne WhitakerBoardroomBreast cancerElesclomolOncologyPharmaceuticalSafi R. BahcallSanofiSynta PharmaceuticalsUSA

uniQure acquires cardiology gene therapy firm InoCard

12-08-2014

Netherlands-based human gene therapy firm uniQure says it has acquired Germany’s InoCard GmbH, an innovative,…

BiotechnologyCardio-vascularGermanyInoCardMergers & AcquisitionsNetherlandsuniQure

Sanofi in $925 million deal to commercialize MannKind’s Afrezza

Sanofi in $925 million deal to commercialize MannKind’s Afrezza

11-08-2014

French pharma major Sanofi has entered into a worldwide exclusive licensing agreement with the USA’s…

AfrezzaDiabetesGlobalInsulin therapyLicensingMannKindPeptide hormonesPharmaceuticalSanofi

201 to 210 of 95973 results

Back to top